Sector: University & Research Institutions

Latest content

‘Fathers of MP3’ call for EU to abandon proposed SEP regulation

IAM talks exclusively to two of the top European scientists speaking out against the “harmful” new licensing framework

29 January 2024

Cloudera’s $240 million verdict crowned largest in US in Q4 2023

The data storage firm’s loss was the fourth-highest award in the last 12 months, with Google’s $338.8 million defeat topping the heap

08 January 2024

Editas licenses CRISPR patents to Vertex in $100 million-plus deal

The speedy agreement prevents litigation between the two parties, but other Cas9 disputes may be on the cards

14 December 2023

First US CRISPR Cas9 approval marks start of new era of patent wars

Friday’s green light from the FDA is watershed for IP strategy in the field

11 December 2023

How a DNA sequencing start-up proved it is no pushover

TwinStrand co-founder’s grandfather famously didn’t patent the polio vaccine, but Dr Jesse Salk believes that protecting inventions is key to getting products to reach the market

05 December 2023

Historic CRISPR drug approval heralds new era in Cas9 IP wars

Green light for first ever Cas9 therapy ushers in next phase of licensing and litigation efforts.

17 November 2023

CRISPR-Cas9 drugmakers like Vertex should come to the table early, says ToolGen’s IP chief

Chief Legal Officer Yoori Kim argues that current patent uncertainty should fuel rather than thwart licensing deals

01 November 2023

Patent transactions in Q2 2023

Featured in Secondary Market Activity

The surge is due to 9,702 US patent assets involved in the BlackBerry sale to Key Patent Innovations, which runs Malikie Innovations, according to the AST Patent Deals Report for Q2 2023

15 September 2023

$227 million Apollo Therapeutics investment is a major boost for innovative tech transfer approach

Pathbreaking joint venture between academia and Big Pharma addresses university IP monetisation challenges

12 September 2023

RegenxBio/Sarepta dispute highlights strategic challenges for gene therapy developers

Narrow safe harbor immunity and platform technology patents are creating both pitfalls and opportunities

08 September 2023

Unlock unlimited access to all IAM content